PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Important Variant Information for ALDH1A1

Submitted by: Ryan Owen (PharmGKB)
Reviewed by: Under Review
Submitted date: Feb 21, 2008

There are Two Important Variants for ALDH1A1.

  1. ALDH1A1*2:
  2. ALDH1A1*3:


1. ALDH1A1*2

Gene HGNC Name: ALDH1A1
Variant Summary: ALDH1A1*2 is a 17bp deletion variant in the promoter region of ALDH1A1, that was first identified by Spence et al through a screening of promoter polymorphisms in diverse ethnic groups (allele frequency table included below) [14506398]. The authors found no significant difference between ALDH1A1*2 expressing constructs and ALDH1A1*1 expressing constructs (the reference sequence) with luciferase assays conducted in both HeLa and HepG2 cells[14506398].

Several studies have attempted to associate the presence of the ALDH1A1*2 allele with alcoholism or alcohol dependence in different populations with conflicting results. The initial discovery study found a non-statistically significant trend in the African American population linking carriers of the ALDH1A1*2 allele with alcoholism[14506398] . Later studies conducted in Indo-Trinidadians seemed to support this contention, as they also observed an association between alcohol dependence and the presence of a ALDH1A1*2 allele [17718398 17286337]. In contrast, studies in Southwest California Indian tribes showed the opposite trend; namely that ALDH1A1*2 was associated with a protective effect against alcoholism [17718395 15597079]. Another study found that ALDH1A1*2 may be associated with a decreased risk of alcoholism in African Americans, contrary to the trend found in the initial discovery study [17718396].

The mechanism for the effect (if any) of ALDH1A1*2 is unclear, but Spence et al suggest that it is possible that the deletion encoded by ALDH1A1*2 may eliminate a c-myb (a putative transcription factor) binding site from the promoter region of ALDH1A1[14506398].
Key PubMed IDs: 14506398 17718398 17718395
Genomic Variant & GenBank ID: Deletion of 45390929-45390945 on AC_000141
mRNA Variant & GenBank ID: N/A
Protein Variant & GenBank ID: N/A
dbSNP rs#: rs6151031
GoldenPath Position: chr9:74758204-74758203 (hg18)
Key Drugs/Substrates: acetaldehyde , retinaldehyde, aldophosphamide
Key Phenotypes/Diseases: Alcoholism


2. ALDH1A1*3

Gene HGNC Name: ALDH1A1
Variant Summary: ALDH1A1*3 is a 3bp insertion variant in the promoter region of ALDH1A1, that was first identified by Spence et al through a screening of promoter polymorphisms in diverse ethnic groups (allele frequency table included below) [14506398]. In contrast to ALDH1A1*2, which was found at low frequencies in every ethnic group examined by Spence et al, ALDH1A1*3 was found specifically in African Americans[14506398].

In vitro luciferase studies in HeLa and HepG2 cell lines suggest that ALDH1A1*3 has significantly lower expression than ALDH1A1*1 (the reference sequence)[14506398]. This suggests that ALDH1A1*3 may not be transcribed as efficiently, and may lead to a reduction in function [14506398] . In seeming agreement with this contention, Spence et al found that the frequency of ALDH1A1*3 was significantly higher among African American alcoholics[14506398] . However, a later study by Scott et al suggested that ALDH1A1*3 actually had a protective effect against alcoholism [17718396].
Key PubMed IDs: 14506398 17718396
Genomic Variant & GenBank ID: Insertion between 45391035-45391035 on AC_000141
mRNA Variant & GenBank ID: N/A
Protein Variant & GenBank ID: N/A
dbSNP rs#: N/A
GoldenPath Position: insertion between chr9:74758298-74758297 (hg18)
Key Drugs/Substrates: acetaldehyde , retinaldehyde, aldophosphamide
Key Phenotypes/Diseases: Alcoholism
Population N Allele Frequency of ALDH1A1*1 Allele Frequency of ALDH1A1*2 Allele Frequency of ALDH1A1*3 Reference
African American 85 0.96
0.01 0.03 14506398
Asian American
71 0.97 0.03 0 14506398
Caucasian 239 0.98 0.02 0 14506398
Jewish 36 0.98 0.02 0 14506398
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.